Cargando…
Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab
Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917490/ https://www.ncbi.nlm.nih.gov/pubmed/35287397 http://dx.doi.org/10.4103/idoj.idoj_223_21 |
_version_ | 1784668557680836608 |
---|---|
author | Mitra, Debdeep Bhatnagar, Anuj Singh, Gautam K. Sandhu, Sunmeet |
author_facet | Mitra, Debdeep Bhatnagar, Anuj Singh, Gautam K. Sandhu, Sunmeet |
author_sort | Mitra, Debdeep |
collection | PubMed |
description | Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not responding to conventional therapy. He had earlier developed a drug reaction to dapsone which is considered the drug of choice for this condition. We report successful management of this case with injection rituximab which is a chimeric monoclonal antibody against CD20, which is primarily found on the surface of B cells. |
format | Online Article Text |
id | pubmed-8917490 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-89174902022-03-13 Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab Mitra, Debdeep Bhatnagar, Anuj Singh, Gautam K. Sandhu, Sunmeet Indian Dermatol Online J Case Report Chronic bullous disease of childhood is a rare subepidermal bullous disease with a hallmark of linear IgA deposition along basement membrane zone seen on direct immunofluorescence. We report a case of a 2-year-old male child, who had recurrent and multiple bullous eruptions over body and he was not responding to conventional therapy. He had earlier developed a drug reaction to dapsone which is considered the drug of choice for this condition. We report successful management of this case with injection rituximab which is a chimeric monoclonal antibody against CD20, which is primarily found on the surface of B cells. Wolters Kluwer - Medknow 2022-03-03 /pmc/articles/PMC8917490/ /pubmed/35287397 http://dx.doi.org/10.4103/idoj.idoj_223_21 Text en Copyright: © 2022 Indian Dermatology Online Journal https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Case Report Mitra, Debdeep Bhatnagar, Anuj Singh, Gautam K. Sandhu, Sunmeet Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab |
title | Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab |
title_full | Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab |
title_fullStr | Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab |
title_full_unstemmed | Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab |
title_short | Successful Treatment of Refractory Chronic Bullous Disease of Childhood with Rituximab |
title_sort | successful treatment of refractory chronic bullous disease of childhood with rituximab |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8917490/ https://www.ncbi.nlm.nih.gov/pubmed/35287397 http://dx.doi.org/10.4103/idoj.idoj_223_21 |
work_keys_str_mv | AT mitradebdeep successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab AT bhatnagaranuj successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab AT singhgautamk successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab AT sandhusunmeet successfultreatmentofrefractorychronicbullousdiseaseofchildhoodwithrituximab |